Activated protein C resistance test using factor VIII-deficient plasma: A new approach to the venous thrombotic risk?
暂无分享,去创建一个
[1] F. Rosendaal,et al. Haplotypes encoding the factor VIII 1241Glu variation, factor VIII levels and the risk of venous thrombosis , 2006, Thrombosis and Haemostasis.
[2] B. Boneu,et al. Comparison of three activated protein C resistance tests in the risk assessment of venous thrombosis in non-carriers of the factor V Leiden mutation , 2006, Thrombosis and Haemostasis.
[3] H. Büller,et al. Absence of mutations at the activated protein C cleavage sites of factor VIII in 125 patients with venous thrombosis , 1996, British journal of haematology.
[4] J. Vandenbroucke,et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis , 1995, The Lancet.
[5] J. Aznar,et al. Modified test for activated protein C resistance , 1994, The Lancet.
[6] Pieter H. Reitsma,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.
[7] B. Dahlbäck,et al. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[8] L. Almasy,et al. A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility. , 2003, Blood.
[9] C. Wagener,et al. Absence of Mutations at the APC Interacting Sites of Factor VIII in Caucasians , 2002, Thrombosis and Haemostasis.
[10] P. Reitsma,et al. High Plasma Concentration of Factor VIIIc Is a Major Risk Factor for Venous Thromboembolism , 2000, Thrombosis and Haemostasis.
[11] M. Laffan,et al. Elevation of FVIII: C in Venous Thromboembolism Is Persistent and Independent of the Acute Phase Response , 2000, Thrombosis and Haemostasis.